Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Single agent infusional 5-fluorouracil is not effective second-line therapy after raltitrexed (Tomudex) in advanced colorectal cancerD C Farrugia, A R Norman, D CunninghamClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1994
Campylobacter fetus endocarditis: two case reports and reviewD C Farrugia, S J Eykyn, E G SmythEuropean Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1995
Primary osteosarcoma of the breastD C Farrugia, A M Rashid, M C ParkerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studiesD C Farrugia, G W Aherne, L Brunton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Balb/c mice as a preclinical model for raltitrexed-induced gastrointestinal toxicityS J Clarke, D C Farrugia, G W Aherne, et al.European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Unknown primary carcinoma: randomised studies are needed to identify optimal treatments and their benefitsD C Farrugia, A R Norman, M C Nicolson, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancerA L Jackman, D C Farrugia, W Gibson, et al.Pageof 1